Oral Treatment with PBI-4425 Decreases Fibrosis in Carbon Tetrachloride (CCL4)-Induced Hepatic Fibrosis Model

Authors :: Alexandra Felton
François Sarra-Bournet
B. Zacharie
Pierre Laurin
Brigitte Grouix
Mikaël Tremblay
Kathy Hince
J.-S. Duceppe
S. Abbott
Lyne Gagnon
Source :: Journal of Hepatology. 64:S228-S229
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oral treatment
medicine.medical_specialty
Hepatology
business.industry
CCL4
medicine.disease
Gastroenterology
chemistry.chemical_compound
chemistry
Fibrosis
Internal medicine
medicine
Carbon tetrachloride
Hepatic fibrosis
business

Full Text Access

Tools